G.D. Tarasova

The review has assessed the benefits of therapy with Kestine. Particular attention is paid to the use of drug for the treatment of perennial rhinitis. It is emphasized that Kestine suppresses not only early but also the late phase of allergic response. The results of the study of the EACCI working group are presented, indicating the proven efficacy of Kestine in acute respiratory infections. The evidence presented allow to conclude that the use of the drug Kestin reduces the need for co-administration of topical decongestants in allergic rhinitis which reduces the cost of therapy.

Similar Articles

Бионика Медиа